Literature DB >> 9637555

Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer.

H Wanebo1, M Coburn, D Teates, B Cole.   

Abstract

SUMMARY BACKGROUND DATA: The extent of primary thyroidectomy for differentiated thyroid cancer is controversial. There are strong proponents for total thyroidectomy based on its presumed and theoretical disease control benefits. In contrast, there are equally strong advocates of less aggressive thyroidectomy with its lower hazard of parathyroid and recurrent nerve injury. The authors have addressed whether total thyroidectomy has a survival benefit justifying its use in patients with high-risk primary cancer. The major risk factors include age and the following the pathologic determinants follicular histology, vascular invasion, and extracapsular extension.
MATERIALS AND METHODS: The clinical pathologic, therapeutic, prognostic, and outcome data were reviewed in 347 patients with well-differentiated thyroid cancer. Seventy-five percent were women, 216 patients were in the younger age group (low-risk) (21-50 years), 103 were in the intermediate-risk group (51-70 years), and 28 were in the high-risk group (>70 years). Included in the high-risk pathologic category were 158 patients who had follicular histology (55), extracapsular extension (107), or vascular invasion (119). Total thyroidectomy was performed in 56 patients, near or subtotal thyroidectomy in 47 patients and lobectomy in 55 patients. The 10-year disease specific survival in the overall patient group was 82% in patients with total thyroidectomy, 78% in patients with subtotal thyroidectomy, and 89% in patients with lobectomy (p = 0.30). There was no significant survival difference according to extent of thyroidectomy in the intermediate or high-risk groups either by age or in patients who had high-risk pathologic feature.
CONCLUSIONS: Total thyroidectomy in high-risk patients with differentiated thyroid cancer (containing follicular histology, vascular invasion, or extracapsular extension) showed no benefit over partial thyroidectomy. This suggests that the general use of total thyroidectomy is not indicated, except in highly selected patients.

Entities:  

Mesh:

Year:  1998        PMID: 9637555      PMCID: PMC1191404          DOI: 10.1097/00000658-199806000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  22 in total

1.  Surgical treatment for thyroid cancer.

Authors:  O H Beahrs
Journal:  Br J Surg       Date:  1984-12       Impact factor: 6.939

2.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.

Authors:  E L Mazzaferri; S M Jhiang
Journal:  Am J Med       Date:  1994-11       Impact factor: 4.965

3.  Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma.

Authors:  B Cady; C E Sedgwick; W A Meissner; J R Bookwalter; V Romagosa; J Werber
Journal:  Ann Surg       Date:  1976-11       Impact factor: 12.969

4.  Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up.

Authors:  J Tennvall; A Biörklund; T Möller; J Ranstam; M Akerman
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

5.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; J R Goellner; J R Ebersold; C S Grant
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

6.  Thyroid cancer: some basic considerations.

Authors:  H J Wanebo; W Andrews; D L Kaiser
Journal:  Am J Surg       Date:  1981-10       Impact factor: 2.565

7.  Further evidence of the validity of risk group definition in differentiated thyroid carcinoma.

Authors:  B Cady; R Rossi; M Silverman; M Wool
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

8.  Differentiated carcinoma of the thyroid with extrathyroidal extension.

Authors:  P E Andersen; J Kinsella; T R Loree; A R Shaha; J P Shah
Journal:  Am J Surg       Date:  1995-11       Impact factor: 2.565

9.  An evaluation of prognostic scoring systems in patients with follicular thyroid cancer.

Authors:  N L Davis; S P Bugis; G I McGregor; E Germann
Journal:  Am J Surg       Date:  1995-11       Impact factor: 2.565

10.  Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer.

Authors:  M C Coburn; H J Wanebo
Journal:  Am J Surg       Date:  1995-11       Impact factor: 2.565

View more
  17 in total

1.  Recurrent laryngeal nerve identification and assessment during thyroid surgery: laryngeal palpation.

Authors:  Gregory W Randolph; James B Kobler; Jamie Wilkins
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

2.  Extent of surgery for differentiated thyroid cancer: recommended guideline.

Authors:  Ganiyu A Rahman
Journal:  Oman Med J       Date:  2011-01

3.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

4.  Mediastinal lymph node involvement as the initial manifestation of occult thyroid cancer in the surgical treatment of lung cancer: report of a case.

Authors:  M Higashiyama; K Kodama; H Yokouchi; K Takami; K Motomura; H Inaji; H Koyama
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Intraoperative frozen section for the evaluation of extrathyroidal extension in papillary thyroid cancer.

Authors:  Young Min Park; Soo-Geun Wang; Jin Young Goh; Dong Hoon Shin; In-Ju Kim; Byung-Joo Lee
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

6.  The Need for Completion Thyroidectomy in Cases of Differentiated Thyroid Cancer.

Authors:  Bayram Veyseller; Alper Yenigun; Fadlullah Aksoy; Aysenur Meric; Orhan Ozturan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-02-17

7.  Retrospective analysis of predictive factors for recurrence after curatively resected papillary thyroid carcinoma.

Authors:  Katsuhiro Tanaka; Hiroshi Sonoo; Mai Hirono; Sumiko Ohkubo; Tsunehisa Nomura; Masahiko Ikeda; Kazukata Nakajima; Junichi Kurebayashi
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 8.  New developments in the diagnosis and treatment of thyroid cancer.

Authors:  David F Schneider; Herbert Chen
Journal:  CA Cancer J Clin       Date:  2013-06-24       Impact factor: 508.702

9.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

Review 10.  Papillary thyroid cancer.

Authors:  J H Yim; G M Doherty
Journal:  Curr Treat Options Oncol       Date:  2000-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.